SOLU-MEDROL 40 mg/1 ml, powder and solvent for solution for injection bottle
Active ingredients: Methylprednisolone hemisuccinate, Methylprednisolone
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent injectable for solution for injectionbottleintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SOLU-MEDROL 40 mg/1 mL, poudre et solvant pour solution injectable
- Pharmaceutical form
- poudre et solvant injectable injectable pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 1 flacon bicompartimenté en verre
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Oct 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60466860CIP73028146CIP133400930281468Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHYLPREDNISOLONEpoudre | 40 mg · un flacon bi-compartimenté | FT |
| HÉMISUCCINATE DE MÉTHYLPREDNISOLONEpoudre | 50,70 mg · un flacon bi-compartimenté | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.